---
title: "Radiopharmaceuticals in Cancer: Promise of Targeted Therapy Meets New Safety Concerns"
id: "stat-news-2-stat-the-promise-of-radiopharmaceuticals-smacks-into-safety-concerns"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-2-stat-the-promise-of-radiopharmaceuticals-smacks-into-safety-concerns"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/08/10/radiopharmaceuticals-clinical-trials-progress-setbacks/?utm_campaign=rss"
published_at: "2026-08-10T08:30:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Radiopharmaceuticals in Cancer: Promise of Targeted Therapy Meets New Safety Concerns
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-2-stat-the-promise-of-radiopharmaceuticals-smacks-into-safety-concerns
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/08/10/radiopharmaceuticals-clinical-trials-progress-setbacks/?utm_campaign=rss)
- **Published At:** 2026-08-10T08:30:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Radiopharmaceuticals have generated significant excitement as a more targeted approach to cancer therapy, aiming to deliver radioactive isotopes directly to tumors rather than exposing large volumes of healthy tissue to external beam radiation. - The central promise is precision: these agents are designed to hit biological "bull’s-eyes" and limit collateral damage compared with traditional radiation. - As more radiopharmaceuticals enter clinical trials, developers are encountering unanticipated safety issues, with some agents affecting non-target organs despite their intended selectivity. - Reported off-target toxicities in the article include damage to the **kidneys**, **liver**, and **bone marrow**, reflecting the virulent nature of the isotopes involved even when delivered in targeted form. - The field has attracted notable industry and investor attention, creating a resurgence or "boom" in radiopharmaceutical drug development described in prior STAT coverage. - The STAT article is a STAT+ exclusive and behind a subscriber paywall; the publicly available excerpt documents broad trends and concerns but does not report detailed trial data, specific products, company names, or regulatory outcomes. - Author and publication details in the source: Allison DeAngelis, STAT, Aug. 10, 2026; she covers biotech startups and venture capital. - Because the article is subscriber-only beyond the excerpt, many granular details — such as specific trial results, company responses, incidence rates, mitigation strategies, or regulatory actions — were not reported in the accessible portion of the source.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/08/10/radiopharmaceuticals-clinical-trials-progress-setbacks/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/10/radiopharmaceuticals-clinical-trials-progress-setbacks/?utm_campaign=rss) [Cancer](https://www.statnews.com/topic/cancer/) [oncology](https://www.statnews.com/topic/oncology/) [research](https://www.statnews.com/topic/research/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Biotech](https://www.statnews.com/category/biotech/) # The promise of radiopharmaceuticals smacks into safety concerns ## Excitement about the cancer treatments persists, but companies are confronting new challenges * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * Email this article * [Share this article](https://www.statnews.com/2026/08/10/radiopharmaceuticals-clinical-trials-progress-setbacks/?utm_campaign=rss) ![](https://www.statnews.com/wp-content/uploads/2026/08/rlt2-2-645x645.jpg) Camille MacMillin/STAT ![](https://www.statnews.com/wp-content/uploads/2022/04/allison-d-avatar-round-80x80.png) By [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) Aug. 10, 2026 Biotech Startups and Venture Capital Reporter ![](https://www.statnews.com/wp-content/uploads/2022/04/allison-d-avatar-round-80x80.png) [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) 1. [](https://x.com/ADeAngelis_bio "X") allison.deangelis@statnews.com Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “[The Readout Loud](https://www.statnews.com/category/readout-loud/).” You can reach Allison on Signal at AllisonDeAngelis.01. In cancer treatment, the pitch has been simple: What if, instead of blasting radiation across patients’ bodies, crop-dusting not only malignant cells but also neighboring healthy tissues, we could shoot chemical weapons directly at only the noxious tumors? That has been the central promise of radiopharmaceuticals, which have grabbed the drug industry’s attention and created a [shining new field of drug development](https://www.statnews.com/2023/11/08/radiopharmaceuticals-boom-times-against-cancer/). But, as more and more of these therapies move into clinical trials, developers are finding it’s not so clear-cut. Advertisement The isotopes that make up radiopharmaceuticals are just as virulent as the beam radiation patients have begrudgingly tolerated for decades. They are designed to be far more targeted. But while they’re hurtling to biological bull’s-eyes, some are inadvertently zapping patients’ kidneys, liver, or bone marrow along the way. STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [Cancer](https://www.statnews.com/topic/cancer/), [drug development](https://www.statnews.com/topic/drug-development/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2022/04/allison-d-avatar-round-80x80.png) [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) 1. [](https://x.com/ADeAngelis_bio "X") 2. Biotech Startups and Venture Capital Reporter 1. [](https://x.com/ADeAngelis_bio "X") 2. Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “[The Readout Loud](https://www.statnews.com/category/readout-loud/).” You can reach Allison on Signal at AllisonDeAngelis.01. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/The-Readout-Logo-Black-640x99.png) ### Newsletter Your morning rundown of the science, politics, and money driving biotech today Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1260243913-80x80.jpeg) [MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get them](https://www.statnews.com/2026/08/05/prostate-cancer-screening-biopsy-vs-mri-debate/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1666307366-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety](https://www.statnews.com/2026/08/05/china-clinical-trial-fatality-safety-questions-investigator-led-studies/) 3. ![](https://www.statnews.com/wp-content/uploads/2024/05/AdobeStock_517947710_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Eli Lilly acquires cancer program from Scorpion Therapeutics in $2.5B deal](https://www.statnews.com/2025/01/13/eli-lilly-scorpion-cancer/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/06/GettyImages-2276972565-80x80.jpg) [One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was](https://www.statnews.com/2026/08/06/mflusiva-fda-mrna-flu-vaccine-rfk-jr/) 5. ![](https://www.statnews.com/wp-content/uploads/2020/07/AdobeStock_170236833-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A pivotal FDA meeting on Biogen’s Alzheimer’s treatment is near. Here’s what you need to know](https://www.statnews.com/2020/10/21/a-pivotal-fda-meeting-on-biogens-alzheimers-treatment-is-near-heres-what-you-need-to-know/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2025/08/VCFirms2025_LeftRailUnit-328x426.png) 2025 Edition: Ranking Biotech’s Top Venture Capital Firms ](https://reports.statnews.com/products/biotech-top-venture-capital-firms-2025) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/06/2026AAIC_Wordpress_CalendarImage-80x80.jpg) AAIC Recap: What’s Next in Alzheimer’s Virtual Jul 16 ](https://www.statnews.com/event/2026-aaic-recap-alzheimers-conference/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_OfficeHours_VirtualEvent_Wordpress_CalendarImage-1-80x80.jpg) Office Hours with STAT’s Bob Herman Virtual Jul 22 ](https://www.statnews.com/event/out-of-pocket-series-bob-herman-office-hours-ama-july-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/07/AdobeStock_2111261602_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Eli Lilly to allow more patients to apply for special access to unapproved obesity drug](https://www.statnews.com/2026/08/03/eli-lilly-retatrutide-mystery-patient-doctors-seek-same-access-their-patients/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/08/AdobeStock_1666307366-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety](https://www.statnews.com/2026/08/05/china-clinical-trial-fatality-safety-questions-investigator-led-studies/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/GettyImages-2245399768-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [NIH plans to block international researchers on visas from accessing key funding avenue ](https://www.statnews.com/2026/08/07/nih-k99-pathways-independence-awards-scientists-on-visas-barred/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/08/C0508954-Tau_protein_clusters_TEM-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Study reveals new role for tau, a top target for Alzheimer’s drug development](https://www.statnews.com/2026/08/06/research-finds-how-tau-targets-cells-structure-alzheimers-drug-development/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/07/MUGSHOT_01-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A most-wanted fugitive appears to have been secretly working as a biotech executive](https://www.statnews.com/2026/07/20/ronald-fischer-rhode-island-fugitive-richard-graydon-biotech/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 10, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed ](https://www.statnews.com/2026/08/10/china-biotech-new-scrutiny-investigator-initiated-trials/) By Brian Yang ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout August 7, 2026 ### [ Is the biotech capital of the world moving? ](https://www.statnews.com/2026/08/07/biotech-news-boston-kendall-square-losing-ground-in-sf/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 7, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: He grew up near Boston, went to Harvard, and worked at MIT. Why did he found his startup in California? ](https://www.statnews.com/2026/08/07/why-did-this-boston-entrepreneur-found-his-biotech-startup-in-california/) By Emma Platoff — Boston Globe ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 6, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves Replimune melanoma drug previously rejected twice ](https://www.statnews.com/2026/08/06/replimune-melanoma-drug-rp1-fda-approves-phase-3-confirmatory-trial/) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech August 6, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Study reveals new role for tau, a top target for Alzheimer’s drug development ](https://www.statnews.com/2026/08/06/research-finds-how-tau-targets-cells-structure-alzheimers-drug-development/) By [Jonathan Wosen](https://www.statnews.com/staff/jonathan-wosen/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety ](https://www.statnews.com/2026/08/05/china-clinical-trial-fatality-safety-questions-investigator-led-studies/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) and Brian Yang 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Startup promising to scale custom CRISPR therapies abruptly scraps plans ](https://www.statnews.com/2026/08/04/aurora-therapeutics-ends-program-baby-kj-treatments-beam-therapeutics-jennifer-doudna/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) and [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Biotech's next big bet: A Tenax study of a heart failure treatment ](https://www.statnews.com/2026/08/06/tenax-study-heart-failure-preview/) By [Adam Feuerstein](https://www.statnew
## Related Clinical Research

- [Moderna and Merck's mRNA Cancer Vaccine: Inside the Melanoma Trial Breakthrough](https://medichelpline.com/clinical-feed/stat-news-0-stat-inside-moderna-and-merck-s-cancer-vaccine-triumph.md)
- [FDA grants accelerated approval to Replimune’s RP1 (Tudriqev) for advanced melanoma](https://medichelpline.com/clinical-feed/stat-news-0-stat-fda-approves-replimune-melanoma-drug-previously-rejected-twice.md)
- [Personalized mRNA vaccine plus pembrolizumab lowers melanoma recurrence in phase 3 trial](https://medichelpline.com/clinical-feed/medical-news-today-0-novel-mrna-vaccine-plus-immunotherapy-reduces-melanoma-relapse-in-phase-3-trial.md)
- [Link Between Daily Sugary Drink Consumption and Increased Stomach Cancer Risk](https://medichelpline.com/clinical-feed/medical-news-today-1-daily-sugary-drink-consumption-linked-to-more-than-double-stomach-cancer-risk.md)
- [Cardiac-targeted delivery strategies for advanced therapies in heart disease](https://medichelpline.com/clinical-feed/pubmed-42284133.md) (DOI: 10.1093/eurheartj/ehag432)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.